• Overarching Political Issues

CEO Update: Monday 18 June

Last week we saw some great news for our sector. The £2.5 billion British Patient Capital fund, launched by the British Business Bank, will provide long-term funding to support the growth of innovative UK bioscience companies and other sectors and will help to build the next generation of UK life science companies to scale to global leadership.

CEO Update: Monday 11 June

Last week, the BIA was out in Boston for BIO 2018. UK companies became Official World record holders, showcasing UK excellence, and partnering and engaging with the international biotech community.

CEO Update Monday 4 June 2018

This week I’m writing from BIO in Boston, one of the largest life science conferences of the year, where BIA has meetings, panels and networking lined up to highlight the strengths of the UK bioscience sector.

BIA comment on Government response to the Health Committee’s report on Brexit and medicines, medical devices and substances of human origin

The BIA has commented on the Government’s response to the Health Committee’s report on Brexit and medicines, medical devices and substances of human origin.

CEO Update: Monday 14 May

Congratulations to Harren Jhoti of BIA member Astex Pharmaceuticals who was made a fellow of the Royal Society last week. He’s our BIA Lifetime Achievement Award winner this year and he’ll be joining me for a fireside chat at our 2018 CEO and Investor Forum on 23-24 May. More on the event in this blog and you can register here.

An Evening with Sir David Cooksey – Highlights from the 2018 BIA Annual Lecture

On Thursday the 3rd of May, delegates from across the sector gathered at the Francis Crick Institute in Kings Cross for the 2018 BIA Annual Lecture. They’d come to meet and hear from one of the titans of UK bioscience – Sir David Cooksey, whose illustrious career has shaped the sector into what it is today. Over the course of the evening, Sir David shared his insight and experiences with the audience in a fireside chat with BIA CEO Steve Bates and SR One Partner Matthew Foy.

CEO Update: Tuesday 8 May 2018

Last week was a busy one for the BIA. On Tuesday we held a webinar ‘Introducing the Broker’ – the first in our new finance series. Our expert speakers from across the world of healthcare finance gave their insight into MiFID II, accessing international funding, approaching brokers and more.

Spotlight on the BIA’s influencing activity in Q1 2018

Every quarter, the BIA publishes a report – ‘Influencing and Shaping our Sector’, covering key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences industry. In this blog, we take a quick look a selection of highlights from the most recent of these updates, covering the period of January to April 2018.

Strategies for Success – Upcoming BIA CEO and Investor Forum 2018

The BIA’s 2018 UK CEO and Investor Forum is now right around the corner, taking place in Buckinghamshire on 23-24 May. It promises to be a jam-packed two days of thought-provoking workshops, panel sessions, and networking (in the form of drinks, archery, and laser clay shooting!). But in all this whirlwind of content it’s important to remember the overarching theme of the event: how UK life science companies can rise to the challenge of thriving in a dramatically shifting landscape. In this blog we take a quick preview of a selection of sessions that’ll be held over the two days, and how they will address this topic.

CEO Update: Monday 30 April 2018

I’d like to start the week with a big congratulation to the BIA team who successfully completed their Tough Mudder challenge on the weekend. It was a gruelling race in tough conditions, but they’ve done us all proud and have raised over £1,300 for Parkinson’s UK, our Charity of the Year for 2018.